Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.560
+0.050 (1.99%)
At close: Jun 26, 2026, 4:00 PM EDT
2.559
-0.001 (-0.05%)
After-hours: Jun 26, 2026, 7:53 PM EDT
Boundless Bio Employees
Boundless Bio had 28 employees as of December 31, 2025. The number of employees decreased by 36 or -56.25% compared to the previous year.
Employees
28
Change (1Y)
-36
Growth (1Y)
-56.25%
Revenue / Employee
n/a
Profits / Employee
-$1,999,786
Market Cap
57.50M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28 | -36 | -56.25% |
| Dec 31, 2024 | 64 | -8 | -11.11% |
| Dec 31, 2023 | 72 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 139 |
| Xilio Therapeutics | 76 |
| aTyr Pharma | 60 |
| PMV Pharmaceuticals | 54 |
| Filana Therapeutics | 20 |
| MiNK Therapeutics | 15 |
| Context Therapeutics | 15 |
| Dogwood Therapeutics | 8 |
BOLD News
- 4 days ago - Boundless Bio, Serapha Bio to combine in all-stock merger - TheFly
- 4 days ago - Boundless Bio Transcript: M&A announcement - Transcripts
- 4 days ago - Boundless Bio Press release: M&A announcement - Filings
- 4 days ago - Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement - GlobeNewsWire
- 7 weeks ago - Boundless Bio reports Q1 EPS (60c), consensus (56c) - TheFly
- 7 weeks ago - Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire
- 7 weeks ago - Boundless Bio Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Boundless Bio Earnings release: Q1 2026 - Filings